BMA (BMA) Stock Price & Analysis

BMA (BMA) rose 4.87% to USD 88 as of June 10, 2026 at 02:25 UTC, according to Nexqual real-time market data.

BMA last closed at USD 83.91; the session ranged USD 84.5–89.3 on volume of 368,328 shares. Market capitalization is $5.63B, with a 52-week range of USD 38.3–106.15 (NYQ). Source: Nexqual, June 10, 2026 at 02:25 UTC.

Key Statistics (as of June 10, 2026 at 02:25 UTC)

PriceUSD 88
Change▲ 4.87% (up)
Previous CloseUSD 83.91
OpenUSD 84.45
Day RangeUSD 84.5 – 89.3
52-Week RangeUSD 38.3 – 106.15
Volume368,328 shares
Market Cap$5.63B
ExchangeNYQ

Technical Analysis (BMA)

Nexqual's technical model rates BMA "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:25 UTC.

Overall SignalBUY
RSI (14)60.01 (neutral)
vs SMA50Above (USD 78.16)
MACD3.3 (positive)

Analyst Ratings (BMA)

Wall Street analysts rate BMA "Strong Buy" based on 9 analysts, with a mean price target of USD 112.42 (range USD 82.32–146.91), per Nexqual as of June 10, 2026 at 02:25 UTC.

Consensus RatingStrong Buy
Analyst Count9
Mean TargetUSD 112.42
High TargetUSD 146.91
Low TargetUSD 82.32
Buy / Hold / Sell9 / 0 / 0

Earnings (BMA)

Next Earnings Date2026-08-26
EPS EstimateUSD 1,976.93
Revenue Estimate$1.34T

Recent Earnings History

QuarterActual vs Estimate
2025-12-31USD 2,313.78 vs est 1,849.8 ▲ beat
2025-09-30USD -551.46 vs est 1,520.42 ▼ miss
2025-06-30USD 2,653.17 vs est 2,607.51 ▲ beat

Source: Nexqual, June 10, 2026 at 02:25 UTC.

Financials & Fundamentals (BMA)

Total Revenue$4.06T
Revenue Growth (YoY)-3.30%
Gross Margin+0.00%
Operating Margin+24.06%
Profit Margin+7.12%
ROE+5.50%
Total Cash$2.64T
Total Debt$1.52T

Source: Nexqual, June 10, 2026 at 02:25 UTC.

Financial Health Score (BMA)

Nexqual rates BMA's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:25 UTC.

GrowthStrong — Revenue +83% YoY (annual)
ProfitabilityCritical — Gross margin 0%
Balance SheetMixed — $2.64T cash vs $1.52T debt, net cash position
Cash FlowWeak — Operating cash flow -$2.06T
EfficiencyMixed — ROE 6%, ROA 1.4%

Ownership (BMA)

Insider Ownership+0.00%
Institutional Ownership+11.88%
Shares Outstanding62.82M
Float21.73M
Short % of Float+2.52%

Source: Nexqual, June 10, 2026 at 02:25 UTC.

Leadership (BMA)

BMA is led by Juan Martin Parma (age 52), Chief Executive Officer, per Nexqual as of June 10, 2026 at 02:25 UTC.

Chief Executive OfficerJuan Martin Parma (age 52)
CFO & Finance ManagerJorge Francisco Scarinci C.F.A. (age 55)

Major Backers & Investors (BMA)

Notable institutional backers of BMA include PointState Capital LP, Samlyn Capital, LLC, Aquamarine Financial (cayman) Ltd, according to Nexqual as of June 10, 2026 at 02:25 UTC.

Active Investors

InvestorStake
PointState Capital LP1.13%
Samlyn Capital, LLC0.87%
Aquamarine Financial (cayman) Ltd0.85%
Turim 21 Investimentos Ltda.0.84%
Morgan Stanley0.77%
TT International Asset Management LTD0.76%
Cape Ann Asset Management Ltd0.75%
GLOBAL X FUNDS-Global X MSCI Argentina ETF0.74%

Index Funds (Passive)

FundStake
BlackRock1.2%

Source: Nexqual, June 10, 2026 at 02:25 UTC.

Peers & Related Stocks

SymbolNamePriceChange
GGALGrupo Financiero Galicia S.A.USD 49.99▲ 4.56%
PAMPampa Energia S.A.USD 82.55▲ 0.77%
SUPVGrupo Supervielle S.A.USD 9.82▲ 3.92%
BBARBanco BBVA Argentina S.A.USD 18.14▲ 3.66%
YPFYPF Sociedad AnonimaUSD 53.61▲ 0.21%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:25 UTC. This page is informational and not investment advice.